Results 101 to 110 of about 7,837 (201)

Does recombinant factor VIIa change the inflammatory response to trauma? Preliminary results of inflammatory biomarkers in critically ill trauma patients [PDF]

, 2006
Matthew Lissauer, Stephen B. Johnson, Thomas M. Scalea, R Dutton, P Maldeis, Richard B. Moore   +5 more
openalex   +1 more source

Correction to: Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia. [PDF]

Ann Hematol, 2018
Tiede A, Worster A.
europepmc   +1 more source

Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres [PDF]

, 2007
Massimo Morfini, G. Auerswald, Rainer Kobelt, G Rivolta, Javier Rodríguez-Martorell, F. A. Scaraggi, Carmen Altisent, Jan Blatný, A. Borel‐derlon, Valentina Rossi   +9 more
openalex   +1 more source

Recombinant Factor VIIa Prophylaxis in 2 Brothers with Bernard-Soulier Syndrome. [PDF]

Am J Case Rep
Almatar E, Alsharidah S, Hashem OA.
europepmc   +1 more source

The Use of Recombinant Factor VIIa in Surgical Bleeding in Nonhemophiliac Patients [PDF]

, 2003
Niamh O’Connell, David J. Perry
openalex   +1 more source

Recombinant nematode anticoagulant protein c2 and other inhibitors targeting blood coagulation factor VIIa/tissue factor [PDF]

, 2003
A. Y. Y. Lee, G P Vlasuk
openalex   +1 more source

Efficacy and Safety Analyses of Recombinant Factor VIIa in Severe Post-Partum Hemorrhage. [PDF]

J Clin Med
Caram-Deelder C, McKinnon Edwards H, Zdanowicz JA, van den Akker T, Birkegård C, Blatný J, van der Bom JG, Colucci G, van Duuren D, van Geloven N, Henriquez DDCA, Knight M, Korsholm L, Landorph A, Lavigne Lissalde G, McQuilten ZK, Surbek D, Wellard C, Wood EM, Mercier FJ.   +19 more
europepmc   +1 more source

Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia. [PDF]

Ann Hematol, 2018
Tiede A, Worster A.
europepmc   +1 more source

Poly-N-Acetylglucosamine Fibers Amplify the Effectiveness of Recombinant Factor VIIA on Clot Formation in Hemophilia B Canine Blood

, 2011
Thomas H. Fischer, Timothy C. Nichols, Christopher M. Scull, Carr J. Smith, Marina Demcheva   +4 more
openalex   +2 more sources

The anticoagulant effects of milvexian, a novel small molecule factor XIa inhibitor, are neutralized by activated prothrombin complex concentrates and recombinant factor VIIa in human plasma and whole blood in vitro. [PDF]

Res Pract Thromb Haemost
Bunce M, Huang Devine Z, Chintala M.
europepmc   +1 more source